Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Market Share

Market Share of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Industry

The acute bacterial skin and skin structure infection market is moderately competitive. The market comprises many small and large market players. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Some of the market players are Glenmark Pharmaceuticals Ltd, Melinta Therapeutics Inc., Sandoz Inc. (a subsidiary of Novartis), Paratek Pharmaceuticals Inc., AbbVie Inc. (Allergan PLC), Merck & Co. Inc., Pfizer Inc., Melinta Therapeutics Inc.

Acute Bacterial Skin and Skin Structure Infection Market Leaders

1. Paratek Pharmaceuticals, Inc.,

2. Melinta Therapeutics, Inc.,

3. Merck & Co., Inc.,

4. Pfizer Inc

5. AbbVie Inc

*Disclaimer: Major Players sorted in no particular order